AIVITA Biomedical Announces U.S. Food and Drug Administration Clearance of IND for Phase II Glioblastoma Multiforme Trial
IRVINE, Calif. – June 20, 2018 – AIVITA Biomedical, a biotech company specializing in innovative stem cell applications, announced today…
AIVITA Biomedical Randomizes First Patient in Phase 2 Ovarian Cancer Trial
IRVINE, Calif. – June 14, 2018 – AIVITA Biomedical announced today the randomization of its first patient in the Company’s…
AIVITA Biomedical Raises $15M USD in Series B Financing
IRVINE, Calif. – June 11, 2018 – AIVITA Biomedical, a global biotech specializing in innovative stem cell applications, announced…
AIVITA Biomedical to Exhibit Skincare Products at Upcoming Conferences for Aesthetic and Skincare Medical Professionals
IRVINE, Calif. – May 9, 2018 – AIVITA Biomedical today announced that it will be exhibiting at two upcoming aesthetics…
AIVITA Biomedical CEO Hans Keirstead to Deliver Plenary Keynote at GTCbio’s 15th Stem Cell Summit
IRVINE, Calif. – April 11, 2018 – AIVITA Biomedical today announced that Chief Executive Officer Hans Keirstead, Ph.D. will be…
AIVITA Biomedical Scientists Invited to Deliver Keynote Address at HAPPI Anti-Aging Conference
IRVINE, Calif. – March 14, 2018 – AIVITA Biomedical, a global biotech specializing in innovative stem cell applications, announced today…
AIVITA Biomedical to Participate at Upcoming February and March Aesthetic & Dermatology Conferences
IRVINE, Calif. – February 27, 2018 – AIVITA Biomedical, a global bio-tech wellness company specializing in novel stem cell applications,…
AIVITA Biomedical Announces First Patient Enrolled in Phase II Clinical Trial for Late-Stage Ovarian Cancer
IRVINE, Calif. – December 20, 2017 – AIVITA Biomedical today announced that the first patient has been enrolled in its…
AIVITA Biomedical Executes Deal with Lacore Labs for Asian Distribution of a New Skincare Line
IRVINE, Calif. – December 07, 2017 – AIVITA Biomedical today announced the execution of a deal with custom formulator and…
AIVITA Biomedical CEO Dr. Hans Keirstead to speak at Exponential Medicine
IRVINE, Calif. – November 6, 2017 – AIVITA Biomedical CEO Dr. Hans Keirstead is scheduled to speak at Exponential Medicine,…